Select to view the solutions available in your location.
Track orders, get results, manage personal information, and more.
Order tests, track orders, get results, and more.
Learn more about our innovative products and services that help detect cancer earlier and power smarter treatment decisions.
Exact Sciences is working to eradicate cancer by delivering a portfolio that gives providers the information they need to better serve their patients across the cancer care continuum — starting with familial risk.
Find out how our scientific rigor, quality standards, and development of future tests make us a leader in cancer testing and treatment guidance.
Exact Sciences expects the test to be available in 2025, pending approval.
Learn all about Exact Sciences, including our purpose, the people who drive it, our history, and the impact we’ve made.
The company’s commitment to community involvement keeps paying off when employees get back from giving back.
Explore stories, news, and events that highlight our innovation, technology, and people fighting cancer on all fronts.
The Riskguard™ test is an assessment tool that can help uncover hereditary cancer risk. The actionable results can help you better understand your patients’ risk level and management options supporting personalized care.
The Riskguard test helps inform the risk stratification for patients who have a family history of cancer by identifying variants in clinically actionable cancer-associated genes, from which you can form a customized path.
The Riskguard test can assist with informing an individualized plan for your patients who have been diagnosed with cancer. Knowing about certain gene variants can help you select optimal treatment.1-6
More ways to personalize patient care
Add the Riskguard test to our OncoExTra™ genomic profiling test to help increase the number of patients with advanced or metastatic cancer that are eligible for targeted therapies.
Pair the Riskguard test with our Oncotype DX Breast Recurrence Score® test to help inform a more comprehensive treatment plan for newly diagnosed ER+/HER2- breast cancer.
We want our results to be simple yet powerful. That’s why we only report on variants in genes you can do something about based on guidelines and published literature. We provide easy-to-understand results that providers and patients can use for personalized care planning. Just the information you need, none of the stuff you don’t.
Call our customer care team for general questions at 1-866-662-6897. You can request the Riskguard test kits and ask about billing, ordering, and how to access results.
Our customer care team can help answer your patients’ questions about the Riskguard test and the testing process. We can also connect them with an independent genetic counselor,* who will take a more detailed family history and provide more in-depth information.
Ask customer care to connect you with one of our genetic counselors for an in-depth consultation. We can help you understand and interpret Riskguard test results, including medical management options for your patient.
Want to help your patients learn more about the Riskguard test? Genetic counselor Brandie Leach breaks down who the test is for, what the testing process is like, and how the results could inform your patient's risk.
Coverage for eligible patients including Medicare and commercial insurance
Specialized support for billing insurance and prior authorization
Flexible payment options for patients
Call customer care at 1-866-662-6897 to request our Riskguard test kits. We can send blood or saliva test kits right to your office, or we can send a convenient at-home saliva test kit directly to your patient's address.†
Download order form below and fax to 1-715-406-4175. If you are collecting a sample in clinic, include a copy of the order form in the specimen kit.
Download order form
OR
Submit an electronic order through the Exact Sciences Provider Hub.
Submit order
You can view your patients’ results on our Exact Sciences Provider Hub. Patients can access their results with their own Exact Sciences account. If they have additional questions, we can connect them to an independent genetic counselor.*
Submit orders, download forms, access test results and more.
See how adding the Riskguard test can give you and your patient powerful information.
Learn more about how the Riskguard test can help guide treatment and prevention.
We're here to help. Our support team can help your patients navigate the insurance coverage process.
Riskguard is a multigene test that may impact clinical decision-making in common cancer types.
See which risk factors and diagnoses make the Riskguard test a fit for your patient.
How much does this test cost?
Most insurance plans cover eligible patients including Medicare and commercial insurance. Out-of-pocket (OOP) costs for the test, if any, are determined by the patient’s insurance company. They may have co-pay, co-insurance, deductible, or non-covered charges as determined by the individual’s plan. We offer flexible payment options to help with their cost.
What is the turn-around-time (TAT)?
You should receive patient results in approximately 14 to 21 days‡ of sample submission.
What if I don't have access to a genetic counselor?
We’ll get you in touch with our genetic counselors who can help you assess your patient’s risk, interpret their results, and review medical management options. Our customer care team can help patients learn about the Riskguard test, explore the testing process, and understand possible results and outcomes or connect them to an independent genetic counselor.
Are your lab and test New York state certified?
Yes. New York State Approval Project ID 93819. For more information visit https://www.wadsworth.org/regulatory/clep/approved-ldt.
Learn More
Provides individualized genomic insights to help customize treatment for patients with HR+, HER2-early-stage breast cancer.
Offers ultra-comprehensive genomic profiling to aid in therapy selection for patients with advanced disease.
Screens average-risk individuals who are 45 years and older for colon cancer (Rx Only).
With questions about ordering the Riskguard test, insurance billing and payment options, checking results, or getting connected with a genetic counselor, call us at 1-866-662-6897 or email us at riskguard@exactsciences.com.
* There may be patient cost associated with independent genetic counseling services.
† Riskguard test kits are provided at no charge and are to be used only with the Riskguard test.
‡ Data on file
References
1 Geyer CE Jr, Garber JE, Gelber RD, et al; OlympiA Clinical Trial Steering Committee and Investigators. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer. Ann Oncol. 2022;33(12):1250-1268.
2 Hussain M, Mateo J, Fizazi K, et al; PROfound Trial Investigators. Survival with olaparib in metastatic castration-resistant prostate cancer. N Engl J Med. 2020;383(24):2345-2357.
3 Golan T, Hammel P, Reni M, et al. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. N Engl J Med. 2019;381:317-327.
4 Ledermann J, Harter P, Gourley C, et al : Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Lancet Oncol. 2014;15:852-861.
5 Domchek SM, Friebel TM, Singer CF, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967-975.
6 Ladabaum U, Wang G, Terdiman J, et al. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med. 2011;155(2):69-79.
The Exact Sciences Riskguard test was developed, and its performance characteristics validated by an Exact Sciences laboratory following College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) regulations. The test is performed in Marshfield, WI at PreventionGenetics LLC, a wholly owned subsidiary of Exact Sciences. PreventionGenetics is accredited by CAP, certified under CLIA regulations, and qualified to perform high-complexity clinical laboratory testing. It has not been cleared or approved by the US Food and Drug Administration or other notified regulatory authority. Genomic Health, Inc., an Exact Sciences company, is the billing entity for Riskguard.